Advertisement
Advertisement
U.S. markets open in 8 hours 34 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Oxford Nanopore Technologies plc (4R0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
2.9620+0.0120 (+0.41%)
At close: 09:15AM CET
Advertisement

Oxford Nanopore Technologies plc

Gosling Building
Edmund Halley Road Oxford Science Park
Oxford OX4 4DQ
United Kingdom
44 84 5034 7900
https://nanoporetech.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees900

Key Executives

NameTitlePayExercisedYear Born
Dr. Gordon S. SangheraCo-Founder, CEO & DirectorN/AN/AN/A
Prof. Hagan Bayley Ph.D.Co-Founder & Member of Technical Advisory BoardN/AN/AN/A
Mr. Tim CowperCFO & DirectorN/AN/AN/A
Mr. Rhodri DaviesVP of OperationsN/AN/AN/A
Mr. Clive G. BrownCTO & DirectorN/AN/AN/A
Mr. John SchoellermanSr. VP of Corp. Devel. & Investor RelationsN/AN/AN/A
Mr. Jordan HermanSr. VP & Gen. CounselN/AN/AN/A
Mr. Richard ComptonSr. VP of Sales & Commercial OperationsN/AN/AN/A
Ms. Sara Agee LeVP of Global MarketingN/AN/AN/A
Ms. Sarah LapworthVP of Global HRN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.

Corporate Governance

Oxford Nanopore Technologies plc’s ISS Governance QualityScore as of December 1, 2022 is 9. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 10; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement